申请人:Oklahoma Medical Research Foundation
公开号:US20040121947A1
公开(公告)日:2004-06-24
Compounds inhibit memapsin 2 &bgr;-secretase activity and selectively inhibit memapsin 2 &bgr;-secretase activity relative to memapsin 1 &bgr;-secretase activity. The compounds are employed in methods to inhibit memapsin 2 &bgr;-secretase activity, in the treatment of Alzheimer's disease, in the inhibition of hydrolysis of a &bgr;-secretase site of a &bgr;amyloid precursor protein and to decrease &bgr;-amyloid protein in in vitro samples and in mammals. Proteins of memapsin 2 associated with compounds of the invention are crystallized.
这些化合物抑制memapsin 2 β-分泌酶活性,并相对选择性地抑制memapsin 2 β-分泌酶活性,而相对于memapsin 1 β-分泌酶活性。这些化合物用于抑制memapsin 2 β-分泌酶活性的方法,用于治疗阿尔茨海默病,用于抑制β淀粉样前体蛋白的β-分泌酶位点的水解,并用于减少体外样本和哺乳动物中的β-淀粉样蛋白。与本发明的化合物相关的memapsin 2蛋白被结晶。